Truist Financial Corp lessened its holdings in shares of Agilent Technologies, Inc. (NYSE:A – Get Rating) by 6.1% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 40,124 shares of the medical research company’s stock after selling 2,592 shares during the quarter. Truist Financial Corp’s holdings in Agilent Technologies were worth $4,877,000 as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds have also recently bought and sold shares of A. Bromfield Sneider Wealth Advisors acquired a new stake in Agilent Technologies during the 2nd quarter worth approximately $31,000. J.W. Cole Advisors Inc. grew its position in Agilent Technologies by 7,201.6% in the first quarter. J.W. Cole Advisors Inc. now owns 124,493 shares of the medical research company’s stock valued at $45,000 after acquiring an additional 122,788 shares in the last quarter. Penserra Capital Management LLC acquired a new stake in Agilent Technologies in the first quarter valued at approximately $60,000. Avondale Wealth Management acquired a new stake in Agilent Technologies in the third quarter valued at approximately $61,000. Finally, WFA of San Diego LLC acquired a new stake in Agilent Technologies in the second quarter valued at approximately $62,000.
Agilent Technologies Stock Performance
A stock opened at $156.49 on Friday. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.47 and a current ratio of 2.03. The stock has a market capitalization of $46.33 billion, a price-to-earnings ratio of 37.53, a PEG ratio of 2.62 and a beta of 1.07. Agilent Technologies, Inc. has a 1 year low of $112.52 and a 1 year high of $160.26. The stock’s fifty day moving average is $150.21 and its two-hundred day moving average is $136.17.
Agilent Technologies Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 25th. Stockholders of record on Tuesday, January 3rd will be issued a dividend of $0.225 per share. This represents a $0.90 dividend on an annualized basis and a dividend yield of 0.58%. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.21. The ex-dividend date is Friday, December 30th. Agilent Technologies’s dividend payout ratio (DPR) is 21.58%.
In other news, CEO Michael R. Mcmullen sold 6,775 shares of the firm’s stock in a transaction on Wednesday, October 19th. The stock was sold at an average price of $130.11, for a total transaction of $881,495.25. Following the transaction, the chief executive officer now directly owns 191,358 shares of the company’s stock, valued at $24,897,589.38. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, CEO Michael R. Mcmullen sold 6,775 shares of Agilent Technologies stock in a transaction dated Wednesday, October 19th. The stock was sold at an average price of $130.11, for a total transaction of $881,495.25. Following the transaction, the chief executive officer now directly owns 191,358 shares of the company’s stock, valued at $24,897,589.38. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, VP Padraig Mcdonnell sold 672 shares of Agilent Technologies stock in a transaction dated Tuesday, December 13th. The stock was sold at an average price of $160.00, for a total value of $107,520.00. Following the transaction, the vice president now directly owns 15,529 shares in the company, valued at $2,484,640. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 222,589 shares of company stock valued at $34,061,140.
Analyst Ratings Changes
Several equities analysts have recently commented on the company. Cowen increased their target price on Agilent Technologies from $160.00 to $168.00 in a research note on Tuesday, November 22nd. Citigroup increased their target price on Agilent Technologies from $145.00 to $150.00 and gave the company a “neutral” rating in a research note on Tuesday, November 22nd. Jefferies Financial Group increased their target price on Agilent Technologies from $158.00 to $168.00 in a research note on Tuesday, November 22nd. Robert W. Baird raised their price objective on Agilent Technologies from $160.00 to $170.00 in a research note on Tuesday, November 22nd. Finally, UBS Group raised their price objective on Agilent Technologies from $152.00 to $170.00 and gave the stock a “buy” rating in a research note on Tuesday, December 20th. Three analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Agilent Technologies has an average rating of “Moderate Buy” and a consensus price target of $161.36.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.
- Get a free copy of the StockNews.com research report on Agilent Technologies (A)
- Deere, Catepillar, PACCAR, Machinery Stocks You Need to Know
- 3 Small-Cap Biopharma Stocks that Could See Big Growth in 2023
- Optimism About Global Demand For Metals Boosts BHP, Other Miners
- Exxon Mobil Expects Earnings and Cash Flow to Grow
- Sorrento Therapeutics, Scilex: 2 Hot Pharma Stocks On the Move
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.